Skip to main content
. 2019 Aug 25;2019:4735876. doi: 10.1155/2019/4735876

Table 4.

Prescription pattern by the drug classes, either included in monotherapy or combination therapy, n (%).

ARB ACEI BETA CCB Diuretics
Overall 150,6561 (51.61) 90,784 (3.11) 539,372 (18.48) 1,314,597 (45.03) 496,634 (17.01)
Age (mean ± SD) 53.01 ± 12.74 53.4 ± 17.74 51.43 ± 16.17 54.32 ± 13.73 54.07 ± 13.81
 <20 6,928 (15.32) 5,564 (12.30) 15,015 (33.20) 7,479 (16.54) 3,092 (6.84)
 20–29 31,458 (32.94) 2,561 (2.68) 35,064 (36.72) 32,134 (33.65) 13,038 (13.65)
 30–39 156,422 (51.54) 7,447 (2.45) 66,968 (22.06) 130,704 (43.06) 48,151 (15.86)
 40–49 415,900 (58.29) 17,660 (2.48) 118,228 (16.57) 315,763 (44.25) 124,418 (17.44)
 50–59 476,338 (54.98) 24,123 (2.78) 142,677 (16.47) 393,807 (45.45) 148,443 (17.13)
 60–69 251,389 (49.42) 17,004 (3.34) 87,818 (17.26) 241,238 (47.43) 86,640 (17.03)
 70–79 131,138 (44.49) 11,737 (3.98) 55,469 (18.82) 145,191 (49.26) 54,624 (18.53)
 ≥80 36,988 (40.38) 4,688 (5.12) 18,133 (19.80) 48,281 (52.71) 18,228 (19.90)
Sex
 Male 904,778 (55.38) 60,192 (3.68) 275,763 (16.88) 775,090 (47.44) 251,286 (15.38)
 Female 601,783 (46.82) 30,592 (2.38) 263,609 (20.51) 539,507 (41.97) 245,348 (19.09)
Income
Medical aid 46,315 (41.27) 3,943 (3.51) 27,160 (24.20) 46,751 (41.66) 19,055 (16.98)
 Q1 (low) 398,887 (52.05) 22,550 (2.94) 139,374 (18.19) 353,498 (46.13) 138,079 (18.02)
 Q2 363,159 (52.13) 20,640 (2.96) 126,485 (18.16) 315,653 (45.31) 121,217 (17.40)
 Q3 346,565 (52.23) 21,268 (3.21) 119,086 (17.95) 299,447 (45.13) 111,549 (16.81)
 Q4 (high) 351,635 (51.68) 22,383 (3.29) 127,267 (18.7) 299,248 (43.98) 106,734 (15.69)
Residence
 Metropolitan 909,496 (52.23) 53,311 (3.06) 320,725 (18.42) 778,121 (44.69) 282,095 (16.20)
 City 430,908 (51.68) 25,320 (3.04) 156,480 (18.77) 375,042 (44.98) 148,404 (17.80)
 Rural 166,157 (48.29) 12,153 (3.53) 62,167 (18.07) 161,434 (46.92) 66,135 (19.22)
Charlson comorbidity index
 0 502,861 (53.60) 12,245 (1.31) 137,490 (14.66) 456,193 (48.63) 163,131 (17.39)
 1 411,171 (51.96) 18,536 (2.34) 136,449 (17.24) 355,466 (44.92) 138,614 (17.52)
 2 252,680 (50.79) 19,096 (3.84) 97,293 (19.56) 212,683 (42.75) 85,095 (17.10)
 ≥3 339,849 (49.10) 40,907 (5.91) 168,140 (24.29) 290,255 (41.94) 109,794 (15.86)
Comorbidity
 Diabetes 240,501 (64.74) 21,283 (5.73) 53,265 (14.34) 127,538 (34.33) 55,124 (14.84)
 Dyslipidemia 465,523 (57.74) 44,577 (5.53) 155,768 (19.32) 331,832 (41.16) 124,074 (15.39)
 Congestive heart failure 45,540 (37.71) 22,783 (18.87) 65,416 (54.18) 37,246 (30.85) 16,936 (14.03)
 Ischemic heart failure 148,348 (36.94) 40,612 (10.11) 161,776 (40.29) 178,876 (44.55) 44,121 (10.99)
 Stroke 67,621 (49.88) 6,568 (4.84) 34,636 (25.55) 66,925 (49.37) 19,360 (14.28)
 Chronic kidney disease 16,310 (59.82) 2,274 (8.34) 5,974 (21.91) 12,220 (44.82) 3,257 (11.95)
 Cancer 13,353 (29.92) 1,531 (3.43) 11,312 (25.35) 24,520 (54.95) 4,385 (9.83)
Provider type
 General hospital 350,910 (37.95) 67,357 (7.29) 316,088 (34.19) 406,074 (43.92) 81,064 (8.77)
 Hospital 161,403 (48.77) 5,958 (1.80) 57,090 (17.25) 176,623 (53.37) 55,586 (16.80)
 Clinic 946,054 (60.62) 14,843 (0.95) 160,542 (10.29) 668,985 (42.86) 339,547 (21.76)
 Others 48,194 (46.82) 2,626 (2.55) 5,652 (5.49) 62,915 (61.12) 20,437 (19.85)
Year
 2011 312,074 (49.75) 21,853 (3.48) 115,374 (18.39) 291,626 (46.49) 132,317 (21.09)
 2012 306,353 (51.24) 20,206 (3.38) 112,748 (18.86) 257,977 (43.15) 117,653 (19.68)
 2013 300,076 (51.87) 18,703 (3.23) 104,476 (18.06) 252,941 (43.73) 94,175 (16.28)
 2014 280,036 (52.01) 15,514 (2.88) 101,408 (18.83) 245,769 (45.64) 76,045 (14.12)
 2015 308,022 (53.38) 14,508 (2.51) 105,366 (18.26) 266,284 (46.15) 76,444 (13.25)